Protalix BioTherapeutics (PLX)

Add to Watchlists Create an Alert
5.20 +0.00  +0.00%   AMEX May 24, 8:00PM BATS Real time Currency in USD

Protalix BioTherapeutics Price / Sales Ratio TTM:

13.34 for May 24, 2013
View Full Chart

Protalix BioTherapeutics Price / Sales Ratio TTM Chart

    Protalix BioTherapeutics Historical Price / Sales Ratio TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 63   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    May 24, 2013 13.34
    May 23, 2013 13.34
    May 22, 2013 13.36
    May 21, 2013 13.36
    May 20, 2013 13.34
    May 17, 2013 13.24
    May 16, 2013 13.39
    May 15, 2013 13.49
    May 14, 2013 13.62
    May 13, 2013 13.42
    May 10, 2013 13.47
    May 9, 2013 13.49
    May 8, 2013 13.62
    May 7, 2013 13.83
    May 6, 2013 13.80
    May 3, 2013 14.16
    May 2, 2013 14.03
    May 1, 2013 14.13
    April 30, 2013 14.54
    April 29, 2013 14.47
    April 26, 2013 14.13
    April 25, 2013 14.24
    April 24, 2013 14.42
    April 23, 2013 14.36
    April 22, 2013 14.24
       
    April 19, 2013 14.21
    April 18, 2013 14.18
    April 17, 2013 14.36
    April 16, 2013 14.31
    April 15, 2013 14.39
    April 12, 2013 14.36
    April 11, 2013 14.36
    April 10, 2013 14.42
    April 9, 2013 14.44
    April 8, 2013 14.29
    April 5, 2013 14.18
    April 4, 2013 14.29
    April 3, 2013 14.36
    April 2, 2013 14.34
    April 1, 2013 14.08
    March 28, 2013 14.08
    March 27, 2013 14.11
    March 26, 2013 14.21
    March 25, 2013 14.13
    March 22, 2013 14.21
    March 21, 2013 14.13
    March 20, 2013 14.31
    March 19, 2013 14.49
    March 18, 2013 13.95
    March 15, 2013 13.83

    About Price to Sales Ratio

    The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.

    An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.
    Learn More

    Get data for

    PLX Price / Sales Ratio TTM Benchmarks

    Companies
    Pfizer 3.743
    Peregrine Pharmaceuticals 9.661
    Shire 4.145

    PLX Price / Sales Ratio TTM Rankings

    Overall 42nd percentile
    4354 of 7600
    Sector 38th percentile
    403 of 653 in Healthcare
    Industry 63rd percentile
    86 of 238 in Biotechnology

    PLX Price / Sales Ratio TTM Range, Past 5 Years

    Minimum 10.46 Nov 6 2012
    Maximum 1526.91 Mar 4 2010
    Average 186.93